IQVIA HOLDINGS INC. Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest
IQVIA HOLDINGS INC. (IQV) had Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest of $6.35 billion as of 2026-03-31, per its 10-Q filed 2026-05-05.
Financial Statements › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest
us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest · last filed 2026-05-05
- 2026-03-31: Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $6.35B.
- 2025-12-31: Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $6.63B.
- 2025-09-30: Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $6.29B.
- 2025-06-30: Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $5.79B.
| Period end | Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest | Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest as first filed |
|---|---|---|
| 2026-03-31 | $6.35B 10-Q · filed 2026-05-05 | |
| 2025-12-31 | $6.63B 10-Q · filed 2026-05-05 | |
| 2025-09-30 | $6.29B 10-Q · filed 2025-10-28 | |
| 2025-06-30 | $5.79B 10-Q · filed 2025-10-28 | |
| 2025-03-31 | $5.99B 10-Q · filed 2026-05-05 | |
| 2024-12-31 | $6.07B 10-Q · filed 2026-05-05 | |
| 2024-09-30 | $6.97B 10-Q · filed 2025-10-28 | |
| 2024-06-30 | $6.71B 10-Q · filed 2025-10-28 | |
| 2024-03-31 | $6.34B 10-Q · filed 2025-10-28 | |
| 2023-12-31 | $6.11B 10-K · filed 2026-02-17 | |
| 2023-09-30 | $5.80B 10-Q · filed 2024-10-31 | |
| 2023-06-30 | $5.75B 10-Q · filed 2024-10-31 | |
| 2023-03-31 | $5.93B 10-Q · filed 2024-10-31 | |
| 2022-12-31 | $5.76B 10-K · filed 2026-02-17 | |
| 2022-09-30 | $5.93B 10-Q · filed 2024-05-02 | $5.35B 10-Q · filed 2022-10-27 |
| 2022-06-30 | $5.35B 10-Q · filed 2023-11-01 | |
| 2022-03-31 | $5.92B 10-Q · filed 2023-11-01 | |
| 2021-12-31 | $6.04B 10-K · filed 2025-02-13 | |
| 2021-09-30 | $5.83B 10-Q · filed 2022-10-27 | |
| 2021-06-30 | $5.76B 10-Q · filed 2022-10-27 | |
| 2021-03-31 | $6.24B 10-Q · filed 2022-10-27 | |
| 2020-12-31 | $6.28B 10-K · filed 2024-02-15 | |
| 2020-09-30 | $6.11B 10-Q · filed 2021-10-22 | |
| 2020-06-30 | $5.85B 10-Q · filed 2021-10-22 | |
| 2020-03-31 | $5.80B 10-Q · filed 2021-10-22 | |
| 2019-12-31 | $6.26B 10-K · filed 2023-02-15 | |
| 2019-09-30 | $6.39B 10-Q · filed 2020-10-22 | |
| 2019-06-30 | $6.78B 10-Q · filed 2020-10-22 | |
| 2019-03-31 | $6.87B 10-Q · filed 2020-10-22 | |
| 2018-12-31 | $6.95B 10-K · filed 2022-02-16 | |
| 2018-09-30 | $7.46B 10-Q · filed 2019-11-01 | |
| 2018-06-30 | $7.61B 10-Q · filed 2019-11-01 | |
| 2018-03-31 | $8.45B 10-Q · filed 2019-11-01 | |
| 2017-12-31 | $8.24B 10-K · filed 2021-02-12 | $8.36B 10-K · filed 2018-02-16 |
| 2017-09-30 | $7.51B 10-Q · filed 2017-10-27 | |
| 2017-06-30 | $7.77B 10-Q · filed 2017-08-04 | |
| 2017-03-31 | $7.80B 10-Q · filed 2017-05-08 | |
| 2016-12-31 | $8.78B 10-K · filed 2020-02-18 | $8.86B 10-K · filed 2017-02-16 |
| 2016-09-30 | -$81.93M 10-Q · filed 2016-11-03 | |
| 2016-06-30 | -$228.70M 10-Q · filed 2016-07-27 | |
| 2016-03-31 | -$205.94M 10-Q · filed 2016-05-03 | |
| 2015-12-31 | -$336.00M 10-K · filed 2019-02-19 | -$335.68M 10-K · filed 2016-02-11 |
| 2015-09-30 | -$179.93M 10-Q · filed 2015-10-28 | |
| 2015-06-30 | -$701.68M 10-Q · filed 2015-07-29 | |
| 2015-03-31 | -$612.31M 10-Q · filed 2015-04-29 | |
| 2014-12-31 | -$703.00M 10-K · filed 2018-02-16 | -$704.01M 10-K · filed 2015-02-12 |
| 2014-09-30 | -$536.23M 10-Q · filed 2014-10-30 | |
| 2014-06-30 | -$621.61M 10-Q · filed 2014-07-31 | |
| 2014-03-31 | -$559.52M 10-Q · filed 2014-05-01 | |
| 2013-12-31 | -$667.00M 10-K · filed 2017-02-16 | -$667.49M 10-K · filed 2014-02-13 |
| 2013-09-30 | -$711.97M 10-Q · filed 2013-10-31 | |
| 2013-06-30 | -$797.89M 10-Q · filed 2013-08-01 | |
| 2013-03-31 | -$1.32B 10-Q · filed 2013-05-14 | |
| 2012-12-31 | -$1.36B 10-K · filed 2016-02-11 | |
| 2011-12-31 | -$969.60M 10-K · filed 2015-02-12 | |
| 2010-12-31 | -$900.36M 10-K · filed 2014-02-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B |